On August 16, 2022, SANUWAVE Health, Inc. appointed Dr. Toni Rinow, age 58, Chief Financial Officer and designated her the principal financial officer of the Company. From April 2020 through December 2021, Dr. Rinow served as CFO and COO of Neptune Wellness Solutions, Inc.; from 2018 through 2019, she served as the Global General Manager of Jubilant Pharma Limited; and from 2016 to 2018, she served as CFO and COO of Isologic Innovative Radiopharmaceuticals. Dr. Rinow holds an MBA and a Masters in Accounting from McGill University in Montreal, Quebec, as well as a chemical engineering degree from ERASMUS European Higher Institute of Chemistry in Strasbourg, France, and a Ph.D. in Biophysics and Chemistry from the University of Montreal.

On August 16, 2022, in connection with Dr. Rinow's appointment as Chief Financial Officer of the Company, Lisa E. Sundstrom transitioned out of the Chief Financial Officer role and was appointed Chief Talent Officer of the Company.